All In MedTech

FDA Clearance Tracker · P110008-S008

coflex® Interlaminar Technology

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 25, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 25, 2018

Approved

Time to decision

303 days

Received Jun 26, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P110008-S008
Device name
coflex® Interlaminar Technology
Applicant location
Merignac Gironde
Received
Jun 26, 2017
Decided
Apr 25, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P110008

Device type

Device class
Class III

Every decision under product code NQO

FDA's approval statement

As written in FDA's record.

Approval for introducing a set of disposable instruments for the coflex® and for Otto Klumpp to manufacture these disposable instruments at Burgstraße 18, 72336, Balingen-Ostdorf, Germany.

Source documents

Other decisions for Companion Spine France

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.